(Nasdaq: ALNY), the leading RNAi therapeutics company, today announced results of new analyses from the HELIOS-B Phase 3 study of AMVUTTRA ® (vutrisiran), an RNAi therapeutic approved for the ...

Danish multinational pharmaceutical company Novo Nordisk’s obesity drug Wegovy (semaglutide 2.4 mg) cut risk of heart attack, ...

The Canadian Climate Institute said Thursday the country's efforts to reduce greenhouse gas emissions "flatlined" in 2024, ...

Harm reduction programs that supply overdose reversal drugs and clean syringes say that the state will see increases in overdose deaths and infectious diseases if the programs go away.

Author Table of Contents Media Contact For general and media inquiries and to book our experts, please contact: ...